SK biopharmaceuticals Co., Ltd.

Develops and commercializes CNS and oncology therapies for global markets, focusing on the U.S.

326030 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 성남시 분당구 판교역로 221, 성남시
Website:: https://www.skbp.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SK Biopharmaceuticals is a global, fully integrated pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies. The company's primary therapeutic area is central nervous system (CNS) disorders, with an expanding pipeline in oncology. Its business model encompasses the entire value chain, from research and development to direct commercialization in key global markets, particularly the United States. The company's flagship product is cenobamate (marketed as XCOPRI® in the U.S.), an anti-seizure medication that has demonstrated significant commercial growth. SK Biopharmaceuticals actively incorporates advanced technologies, including artificial intelligence, to accelerate its drug development process and address unmet medical needs.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SK biopharmaceuticals Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-09-16 00:00	Regulatory News Service 투자판단관련주요경영사항	Korean	12.8 KB
2025-08-29 00:00	Regulatory News Service 대규모기업집단현황공시[분기별공시(개별회사용)]	Korean	5.9 KB

Automate Your Workflow. Get a real-time feed of all SK biopharmaceuticals Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SK biopharmaceuticals Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
JCR Pharmaceuticals Co.,Ltd. Develops therapies for rare genetic diseases, CNS disorders, and regenerative medicine.	Japan	4552
JEIL PHARMACEUTICAL CO.,LTD Global manufacturer of pharmaceutical APIs, antibiotics, and injection-based treatments.	South Korea	271980
JEIL PHARMA HOLDINGS INC. Develops and distributes APIs, generics, and modified drugs, specializing in injections.	South Korea	002620
JETEMA Co.,Ltd. Research-driven developer of aesthetic toxins, dermal fillers, and threads.	South Korea	216080
JIN YANG PHARMACEUTICAL. CO., LTD Develops and manufactures high-tech drugs for cancer, diabetes, and a range of diseases.	South Korea	007370
JW LIFESCIENCE CORPORATION A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.	South Korea	234080
JW SHINYAK CORPORATION Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.	South Korea	067290
Kadimastem Ltd. Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.	Israel	KDST
kainos loboratories,inc Develops, manufactures, and sells innovative clinical diagnostic reagents for the healthcare industry.	Japan	4556
KAKEN PHARMACEUTIAL CO., LTD. R&D pharma firm creating drugs & devices for orthopedics, dermatology, and surgery globally.	Japan	4521